DAMAI ENT Reports Annual Profit Surge of 94% to CNY 7.05 Billion

Stock News
05/27

DAMAI ENT (01060) announced its annual results for the period ending March 31, 2026. The company reported revenue of approximately CNY 80.24 billion, representing a 20% year-on-year increase. Net profit attributable to owners of the company reached about CNY 7.05 billion, a significant 94% rise compared to the previous year. Basic earnings per share were 2.38 fen.

During the reporting period, China's live entertainment market continued its robust growth, with box office revenue for performances showing steady increases for three consecutive years. In 2025, annual performance box office revenue historically surpassed CNY 600 billion, marking a 6.39% growth from 2024. The number of performances exceeded 600,000, up 6.58% year-on-year, while audience attendance reached 194 million, increasing by 4.22%.

Leveraging these industry opportunities, the DAMAI platform achieved continuous growth in its Gross Merchandise Value (GMV) for performance tickets over three years, maintaining its leading position in the sector. The group provided ticketing services for over 400,000 performances during the period, recording double-digit growth that outpaced the industry average.

In the series production segment, the group intensified investments in premium content through its studio operating model, consistently delivering high-quality productions that gained widespread recognition from audiences and the market. Several well-received series, including "In the Name of Law," "Blazing Youth," and "Tang Palace Mystery: Whistle in the Green Mist," were broadcast during the period. Additionally, series such as "Prosecution," "Marrying the Golden Hairpin," and "Doctor's Honor" have completed filming and are awaiting release. The series studios currently have over 20 key projects in the pipeline.

The series production division reported revenue of approximately CNY 14.01 billion, more than doubling from about CNY 5.78 billion in the previous period, representing growth exceeding 100%. Division performance reached around CNY 1.51 billion, also more than tripling from approximately CNY 470 million in the prior period, with growth surpassing 100%.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10